Afecta Pharmaceuticals
Creating Precision Medicines...More Efficiently
8 employees · Irvine, United States
Pharvaris is the larger of the two.
Side-by-Side Comparison
| Metric | Afecta Pharmaceuticals | Pharvaris |
|---|---|---|
| Founded | ||
| Founded | Not tracked yet | 2015 |
| Headquarters | ||
| Headquarters | Irvine, United States | Zug, Switzerland |
| Employees | ||
| Employees | 8 | 139 larger |
| Industry | ||
| Industry | Health Care, Health and Wellness, Pharmaceutical | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $967.33M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 8 |
| Services | ||
| Services | Precision medicines development, AI computational platforms for drug design, Drug delivery technologies | Development of oral bradykinin B2 receptor antagonists, Research and clinical trials for hereditary and acquired angioedema, Providing oral alternatives to traditional injection therapies |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Healthcare professionals, Patients with chronic diseases, Cancer patients | Patients with hereditary angioedema (HAE), Patients with acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), Healthcare providers managing bradykinin-mediated conditions |
| Taxonomy | ||
| Taxonomy | Precision Medicines, Small Molecule Therapeutics, Drug Discovery, Multi-Target Drugs, Tissue-Specific Drug Delivery, Neurology, Oncology, Neurodevelopmental Disorders, PharmetRx® Platform, NanoRx® Technology, Clinical Development, Preclinical Development, Medicinal Chemistry, Pediatrics | Clinical-stage Biotechnology, Bradykinin-B2-Receptor Antagonists, Oral Therapeutics Development, Rare Disorders, Hereditary Angioedema, Small Molecule Drug Discovery, Pharmaceutical Development, Novel Therapeutics, Phase 1 Clinical Trials, Drug Candidate Development, Innovative Medicine, Receptor-mediated Diseases, Non-injectable Therapies, Biotech Leadership |
| Website | ||
| Website | afectapharm.com | pharvaris.com |
About Afecta Pharmaceuticals
Afecta Pharmaceuticals, under the slogan "Creating Precision Medicines...More Efficiently", represents a promising venture in the pharmaceutical industry. Specializing in precision medicines, it aims to effectively address chronic disorders and cancers. The company's proprietary Artificial Intellige...
About Pharvaris
Pharvaris, founded in 2015, is a Switzerland-based clinical-stage company at the forefront of developing oral treatments for bradykinin-mediated diseases such as hereditary angioedema (HAE). The company’s slogan, "Pioneering science for patient choice", reflects its dedication to innovative therapeu...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Afecta Pharmaceuticals and Pharvaris — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Afecta Pharmaceuticals and Pharvaris — by email.
Frequently Asked Questions
Compare Afecta Pharmaceuticals with someone else
Start typing a company name or domain.